Divisão de Pneumologia, Instituto do Coração, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil; Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil.
Departament of Physical Therapy, School of Medicine, University of Sao Paulo, Sao Paulo, SP, Brazil.
Pulmonology. 2024 Nov-Dec;30(6):563-569. doi: 10.1016/j.pulmoe.2022.04.009. Epub 2022 Jul 16.
The cardiopulmonary exercise test (CPET) is the gold standard for assessing aerobic fitness; however, it is expensive, not widely available, and requires specialized equipment and staff. The incremental shuttle walking test (ISWT) is an exercise field test used to evaluate exercise capacity and may be an alternative to CPET in patients with lymphangioleiomyomatosis (LAM).
To investigate whether the ISWT can be used to assess maximal aerobic capacity in patients with LAM.
Forty-five women were evaluated on two days, and they randomly performed the CPET and ISWT. The maximum oxygen uptake (peak VO) was evaluated using gas analyzers in both tests. The carbon dioxide production (VCO), respiratory exchange ratio (RER), and heart rate (HR) were compared during peak exercise. Pearson's correlation and Bland-Altman assessed the association and agreement, respectively. The intraclass correlation coefficient (ICC) was used to assess the reliability of the data.
All patients (46.1 ± 10.2 years) presented similar peak VO, RER, and peak HR during the CPET and ISWT (15.6 ± 4.6 vs. 15.7 ± 4.4 ml·kg·min; 1.15±0.09 vs. 1.17±0.12; and 142.2 ± 18.6 vs. 141.5 ± 22.2 bpm, respectively; p>0.05). A good linear correlation (r = 0.79; p<0.001) and ICC (0.86; 95%CI 0.74-0.93) were observed between the peak VO in both tests. Predictive peak VO equations based on the ISWT performance are also presented.
Our results suggest that the ISWT can be used to assess maximal exercise performance in patients with LAM, and it is a valuable option to be used as an alternative to the CPET and predict maximal exercise capacity.
心肺运动测试(CPET)是评估有氧健身的金标准;然而,它昂贵、普及性不高,且需要专门的设备和人员。递增式踏步测试(ISWT)是一种用于评估运动能力的运动现场测试,在淋巴管平滑肌瘤病(LAM)患者中可能是 CPET 的替代方法。
探讨 ISWT 是否可用于评估 LAM 患者的最大有氧能力。
45 名女性在两天内进行评估,她们随机进行 CPET 和 ISWT。在两项测试中均使用气体分析仪评估最大摄氧量(peak VO)。比较峰值运动时的二氧化碳产量(VCO)、呼吸交换比(RER)和心率(HR)。Pearson 相关和 Bland-Altman 分别评估关联和一致性。使用组内相关系数(ICC)评估数据的可靠性。
所有患者(46.1 ± 10.2 岁)在 CPET 和 ISWT 中均表现出相似的 peak VO、RER 和 peak HR(15.6 ± 4.6 与 15.7 ± 4.4 ml·kg·min;1.15±0.09 与 1.17±0.12;142.2 ± 18.6 与 141.5 ± 22.2 bpm,分别;p>0.05)。两项测试的 peak VO 之间存在良好的线性相关性(r = 0.79;p<0.001)和 ICC(0.86;95%CI 0.74-0.93)。还提供了基于 ISWT 表现的预测 peak VO 方程。
我们的结果表明,ISWT 可用于评估 LAM 患者的最大运动表现,并且是替代 CPET 和预测最大运动能力的有价值选择。